Ayurvedic drug helps cut down heart attack risk: Study
New Delhi: Ayurvedic medicines developed by Council of Scientific & Industrial Research (CSIR) is proving a great help for patients suffering from blood sugar ailments as the latest study has reported that the ayurvedic medicines have the efficacy of reducing the risk of heart attacks in patients suffering from diabetics by up to 50 per cent.
According to the latest study published in the Journal of Traditional and Complementary Medicine, it was found that glycosylated haemoglobin level, tested to monitor the long-term control of diabetes mellitus, of at least half of the patients who had participated in the clinical trial for the herbal drug was under control.
The results hold importance given that achieving near-normal glycated haemoglobin (HbA1c) significantly decreases the risk of microvascular and macrovascular complications causing organ and tissue damage, an official said.
Glycosylated haemoglobin is the haemoglobin in the Red Blood Cells (RBCs) to which glucose is bound.
As per the study, the clinical trial of the anti-diabetic potential of BGR-34 was conducted as per the Indian Council of Medical Research (ICMR) guidelines on conducting trials of ayurvedic substances.
The drug was jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plant (CIMAP), the official said.
- 22 Aug 2019 6:17 PM GMT
- 1 May 2017 6:52 PM GMT
- 8 Oct 2019 4:43 PM GMT
- 31 Aug 2019 1:38 PM GMT
- 25 Oct 2017 3:32 PM GMT
- 12 Dec 2019 6:28 PM GMT
- 12 Dec 2019 6:26 PM GMT
- 12 Dec 2019 6:23 PM GMT
- 12 Dec 2019 6:22 PM GMT
- 12 Dec 2019 6:21 PM GMT